全文获取类型
收费全文 | 1930篇 |
免费 | 151篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 110篇 |
妇产科学 | 50篇 |
基础医学 | 299篇 |
口腔科学 | 72篇 |
临床医学 | 200篇 |
内科学 | 375篇 |
皮肤病学 | 101篇 |
神经病学 | 86篇 |
特种医学 | 247篇 |
外科学 | 156篇 |
综合类 | 35篇 |
一般理论 | 3篇 |
预防医学 | 112篇 |
眼科学 | 27篇 |
药学 | 111篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 112篇 |
出版年
2022年 | 15篇 |
2021年 | 15篇 |
2020年 | 23篇 |
2019年 | 17篇 |
2018年 | 43篇 |
2017年 | 13篇 |
2016年 | 33篇 |
2015年 | 41篇 |
2014年 | 51篇 |
2013年 | 61篇 |
2012年 | 64篇 |
2011年 | 59篇 |
2010年 | 88篇 |
2009年 | 77篇 |
2008年 | 60篇 |
2007年 | 82篇 |
2006年 | 85篇 |
2005年 | 62篇 |
2004年 | 61篇 |
2003年 | 65篇 |
2002年 | 46篇 |
2001年 | 35篇 |
2000年 | 25篇 |
1999年 | 38篇 |
1998年 | 93篇 |
1997年 | 86篇 |
1996年 | 66篇 |
1995年 | 58篇 |
1994年 | 45篇 |
1993年 | 50篇 |
1992年 | 23篇 |
1991年 | 32篇 |
1990年 | 32篇 |
1989年 | 52篇 |
1988年 | 49篇 |
1987年 | 38篇 |
1986年 | 28篇 |
1985年 | 30篇 |
1984年 | 18篇 |
1983年 | 19篇 |
1982年 | 22篇 |
1981年 | 17篇 |
1980年 | 20篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 10篇 |
1942年 | 7篇 |
1940年 | 8篇 |
1938年 | 7篇 |
排序方式: 共有2103条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Pyomyositis: characteristics at CT and MR imaging 总被引:9,自引:0,他引:9
5.
H. -J. Möller H. M. van Praag B. Aufdembrinke P. Bailey T. R. E. Barnes J. Beck H. Bentsen F. X. Eich L. Farrow W. W. Fleischhacker J. Gerlach K. Grafford B. Hentschel A. Hertkorn S. Heylen Y. Lecrubier J. P. Leonard P. McKenna W. Maier V. Pedersen A. Rappard W. Rein J. Ryan M. Sloth Nielsen R. -D. Stieglitz G. Wegener J. Wilson 《Psychopharmacology》1994,115(1-2):221-228
There is little agreement about the methodology of clinical trials of antipsychotic drugs in patients with negative symptoms. A literature review revealed wide variation in experimental design, rating scales and study duration. This reflects differing views as to the definition and response to treatment of negative symptoms. Some degree of standardization would improve comparability of studies and aid the development of new compounds. Patients included in such studies should have displayed negative symptoms for at least 6 months. Depressive symptoms, positive schizophrenic symptoms and extrapyramidal signs may all influence or be confused with negative symptoms and may respond to treatment; they should be at a low level at baseline and should be measured during the study period. Studies should last at least 8 weeks. Several scales are available for measuring negative symptoms and are reviewed; a global impression score should be used additionally. 相似文献
6.
7.
D De AJ Kanwar S Handa 《Journal of the European Academy of Dermatology and Venereology》2006,20(7):853-859
BACKGROUND: Diagnosis of atopic dermatitis (AD) depends on clinical features because no definitive diagnostic test exists. Criteria proposed by Hanifin and Rajka (Acta Derm Venereol (Stockh) 1980; Suppl 92: 44-47) were acceptable for hospital-based studies but were found not to be suitable for field studies. A UK working party formulated clinical diagnostic criteria that could be used in both hospital and epidemiological settings. Validation studies of the criteria showed widely variable results, probably due to different clinical settings and ethnicity. AIM AND OBJECTIVE: This study was undertaken to validate Hanifin and Rajka's criteria and to assess the comparative efficacy of their criteria and the UK working party's diagnostic criteria in the diagnosis of AD in a hospital setting in North India. SUBJECTS AND METHODS: This study serially included 101 patients with AD and 48 controls of paediatric age group. The study period was from July 2003 to December 2004. RESULTS: Hanifin and Rajka's criteria (sensitivity 96%, specificity 93.75%, positive predictive value 97% (PPV) and negative predictive value (NPV) 91.84%) had a statistical advantage over the UK working party's diagnostic criteria (sensitivity 86%, specificity 95.83%, PPV 97.75% and NPV 76.67%), with a P-value < 0.005. 相似文献
8.
SUMMARY Impotence is a common symptom which can cause considerable distress to both the sufferer and his partner. The use of pharmacotherapy to improve erectile function will continue to increase as safe and effective drugs are developed. However, restoring erectile function should not be the only treatment objective. It is also essential to address personal and emotional factors in the sufferer, conflicts in his relationship with his partner, and sexual problems in his partner, all of which may be instrumental in causing or maintaining the presenting impotence. We advocate a combined approach with appropriate medical treatment and sex and couple therapy 相似文献
9.
We describe how adverse drug reactions (ADRs) can play an important role in pharmaceutical research and drug development. Not only do ADRs represent the risks and drawbacks associated with drugs but they can also be related to other knowledge available in pharmaceutical and medical research. We offer a model that can be used to systematically map the pathways through which ADRs can lead to innovative research. These pathways include chemical, therapeutic or pathophysiological steps that can be taken to arrive at new knowledge based on ADRs. We used the development of angiotensin-converting enzyme inhibitors, especially captopril, as a case study. The similarity between the ADR profiles of captopril and penicillamine was a starting point for further innovation. Historical analysis shows that in several instances research in the field of angiotensin-converting enzyme inhibitors has been triggered by ADRs. The model presented here might be applicable to other areas of innovative drug research. 相似文献
10.